In the media 26 Jun 2024 Framework to help curb visceral leishmaniasis in East Africa Health Policy Watch
In the media 25 Jun 2024 Consider This: Dengue vaccine (part 3) — Pandemic lessons: Prevent vaccine inequity Astro Awani
Press releases 24 Jun 2024 Paediatric malaria treatment developed in Brazil by not-for-profit organizations distributed to Indigenous children in the Amazon region
In the media 22 Jun 2024 What role does capacity development play in transforming health research? Health Policy Watch
Press releases 12 Jun 2024 New framework for visceral leishmaniasis elimination launched for Eastern Africa
Scientific articles 31 May 2024 Demystifying in vivo bioluminescence imaging of a Chagas disease mouse model for drug efficacy studies Journal of Visualized Experiments
Stories 23 May 2024 Defying the odds: One doctor’s remarkable journey to helping patients with kala-azar
Press releases 31 Jan 2018 Sanofi, DNDi seek European Medicines Agency review for sleeping sickness treatment
Press releases 13 Nov 2017 Pharmaniaga, Pharco and DNDi sign agreement to provide affordable hepatitis C treatment in Malaysia
Press releases 8 Nov 2017 DNDi/GARDP opens new South Africa liaison office, hosted by South African Medical Research Council
Press releases 4 Nov 2017 Phase II/III studies show high efficacy and safety of fexinidazole, the first oral treatment for sleeping sickness
Press releases 20 Sep 2017 DNDi welcomes Malaysia’s move to secure access to more affordable treatments for hepatitis C
Press releases 4 Sep 2017 More than EUR 56 million raised to fund initiative to fight antibiotic resistance
Press releases 31 Aug 2017 U.S. FDA approves Chemo Group’s benznidazole to treat children with Chagas disease
Press releases 8 Aug 2017 DNDi welcomes Dr Marie-Paule Kieny as new Chair of the Board of Directors with Prof. Marcel Tanner stepping down after ten successful years
Press releases 6 Jul 2017 Entasis Therapeutics and the Global Antibiotic Research & Development Partnership (GARDP) to develop a new treatment for drug-resistant gonorrhea
Press releases 6 Jun 2017 Child-friendly formulation of WHO-recommended HIV treatment now approved by the CDSCO
Press releases 3 May 2017 New open source project engages universities in neglected diseases drug discovery
Press releases 19 Apr 2017 Merck joins DNDi’s ‘Drug Discovery Booster’ to accelerate discovery of new treatments for neglected diseases
Press releases 13 Apr 2017 First large-scale survey of Chagas disease in the United States confirms that the “Silent Killer” is a major public health challenge for the country